Virtual Company

AKL Research & Development Limited (“AKL”) is a privately held, virtual, emerging pharmaceutical development company domiciled in the UK with a pioneering approach to drug development.

AKL operates a lean, virtual business model recruiting specialist expertise as required to guide product development. The majority of AKL’s team are equity incentivised, enabling cash-burn offset & overhead reduction.

AKL was founded by:

Dr. Nicholas Larkins BVSc DSc MRCVS

Veterinarian with extensive research interests in pharmacognosy specifically focused on immunomodulatory phytochemicals and the roles they play in inflammation and the resolution of inflammation.

David Sharples

Entrepreneur with successful track record with multiple start-up companies, experienced in recruiting and supervising strong management teams.

Richard Cleeve

Founder and MD of Natural Animal Feeds (“NAF”) established in 1983, Europe’s leading brand of nutraceuticals for the equine market that has recently expanded into the small animal and human markets.

Lord Grade CBE

Non-Executive Chairman of Pinewood and Shepperton Studios. High profile career in the broadcast media as a top executive at the BBC, Channel 4, Embassy Television and LWT.